Merging of Nano Dimension with Desktop Metal and Markforged Will Have the Scale and Capital to Drive to Profitable Expansion With a Combined 2023 Revenue of $340M Cash & Cash Equivalents Expected at Close of ~$475M The Combined Company Further Increases Value Creation Opportunity With an Even Broader AM/3D Printing Portfolio Technologies Intended for True Manufacturing Applications Nano Dimension and Markforged to Hold Joint Investor Call to Discuss the Transaction Tomorrow, Thursday, September 26th, at 8:30 AM ET WALTHAM, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension”) and Markforged Holding Corporation (NYSE: MKFG) (“Markforged”) today jointly announced that they have entered into a definitive agreement pursuant to which Nano Dimension will acquire all outstanding shares of...

Global Contrast Media Market size was valued at USD 6.55 billion in 2023 to USD 11.60 billion by 2031, growing at a CAGR of 7.4% during the forecast period (2024-2031). Westford, USA, Sept. 25, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Contrast Media Market will attain a value of USD 11.60 billion by 2031, with a CAGR of 7.4% over the forecast period (2024-2031). The growing number of diagnostic imaging procedures performed around the world are primarily driving the demand for contrast media. Surging incidence of chronic illnesses and advancements in imaging technologies are also anticipated to favor contrast media market development over the coming years.   Browse in-depth TOC on “Contrast Media Market”  Pages – 197 Tables – 95 Figures – 76 Contrast Media Market Overview: Report Coverage  Details Market...

GRAPEVINE, Texas, Sept. 25, 2024 (GLOBE NEWSWIRE) — Buchanan Technologies, a leading IT and Application Managed Services provider, has acquired Dallas-based Heartland IT, an IT services firm with primary expertise in Oracle technologies, including Oracle Fusion Applications (OFA), Oracle Cloud Infrastructure (OCI), Oracle EBS, JD Edwards, and PeopleSoft. This marks the third acquisition Buchanan has completed in the last three years centered around its Oracle solutions. Heartland IT was founded in 2010 with a vision to be the premier Oracle consulting firm providing services to multi­national organizations. With exceptional delivery expertise in Oracle technologies and a robust grasp of the needs of diverse industries, Heartland IT has created innovative solutions for its tenured customer base, assisting clients with their journey...

Global Medical Billing Outsourcing Market size was valued at USD 12.2 billion in 2023 to USD 30.2 billion by 2031, growing at a CAGR of 12.03% in the forecast period (2024-2031). Westford, USA, Sept. 25, 2024 (GLOBE NEWSWIRE) — The medical billing outsourcing market is growing extensively mainly due to bad debts & uncollectable accounts, emergence of advanced technological solutions, and changing government guidelines. Medical billing outsourcing can assist in minimizing the expenses of equipment and software, enhance cash flow, and enables companies to reduce employee size and expense. With the increasing utilization of IT resources in the medical business and robust government support, the market is growing exponentially. Furthermore, the increasing expense of medical, especially in the developed economies has increased...

YD Biopharma is a Clinical-Stage Biopharmaceutical Company Focusing on Cancer Prevention Diagnostics and Seeking to Transform the Treatment of a Wide Spectrum of Diseases Pro Forma for the Transaction, Combined Company is Expected to Have an Estimated Enterprise Value of Nearly $700 Million The Proposed Merger is Expected to Close by Early 2025; After Closing, the Combined Company is Expected to be Listed on Nasdaq Capital Market YD Biopharma has Recently Obtained Patents, Technology, and U.S. Authorization for Core Methylation Detection of Pancreatic Cancer, Along with Entering into an Agreement to Acquire Licenses for Breast Cancer Detection Upon the Closing of the Merger IRVING, Texas, Sept. 25, 2024 (GLOBE NEWSWIRE) — Breeze Holdings Acquisition Corp. (OTCQX: BRZH, BRZHR, BRZHW) (“Breeze” or the “Company”), a publicly traded...

TORONTO, Sept. 24, 2024 (GLOBE NEWSWIRE) — Middlefield Global Real Asset Fund (“Real Asset”) (TSX:RA.UN) is pleased to announce that a special meeting of unitholders of Real Asset was held today at which unitholders voted in favour of a resolution approving the previously announced merger (the “Merger”) of Real Asset into Real Estate Split Corp., a split share corporation founded on November 19, 2020, which invests in a diversified, actively managed, high conviction portfolio of issuers engaged in e-commerce and data infrastructure as well as the multi-family, industrial, retail, seniors housing and healthcare sectors. The Merger is expected to be completed on or about December 6, 2024 (the “Effective Date”). The investment objectives of Real Estate Split Corp. are to provide:Holders of Class A shares with:  (i) non-cumulative...

-Metabolomics Diagnostics, a deep-tech machine learning diagnostic platform developer, has developed an innovative test, PrePsia, to accurately predict the risk of preeclampsia in pregnant women- -The PrePsia test can predict preeclampsia risk as early as in the 12th week of pregnancy, allowing for early interventions to prevent serious health issues for mothers and their babies- -PrepSia will be commercialized in the U.S. market in 2025 through Trinity Biotech’s New York-based Immco reference laboratory- DUBLIN, Sept. 24, 2024 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has acquired privately held Metabolomics Diagnostics, an Irish deep-tech company, specialized...

Shipsi gives any retailer the power to offer customers instant one-hour delivery MIAMI, Sept. 24, 2024 (GLOBE NEWSWIRE) — Rainmakers today announced it had acquired the on-demand delivery and logistics technology, Shipsi, from Auctane. Shipsi is the technology leveling the “instant shipping” playing field in retail. Shipsi believes this acquisition will usher in a new era of AI-driven, ultra-fast delivery solutions for retailers of all sizes and looks forward to continuing to enhance its ability to transform retail logistics through ongoing innovation and support from trusted partners, ensuring a seamless and improved experience for both retailers and consumers. Shipsi’s technology gives retailers the power to offer same-day shipping by mobilizing last-mile networks to deliver goods. To date, Shipsi has given thousands...

LEHI, Utah, Sept. 24, 2024 (GLOBE NEWSWIRE) — Complete Solar Holdings, Inc. d/b/a Complete Solar (“Complete Solar” or the “Company”) (Nasdaq: CSLR), a solar technology, services, and installation company, today announced that the United States Bankruptcy Court for the District of Delaware has approved the going concern sale of substantially all assets of the Blue Raven, New Homes and Dealer businesses of SunPower Corporation and certain of its affiliates to Complete Solar for $45 million in cash. The sale is expected to close on or before Monday, September 30, 2024, at which time SunPower businesses, the SunPower brand, and about 1,000 employees will become part of Complete Solar, the temporary name of SunPower during this transition. T.J. Rodgers, Complete Solar’s CEO, commented “This is a pivotal moment in the history of SunPower,...

Wearable Injectors Market size was valued at USD 7.65 billion in 2023 to USD 23.89 billion by 2031, growing at a CAGR of 15.29% in the forecast period (2024-2031). Westford, USA, Sept. 24, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Wearable Injectors Market will reach a value of USD 23.89 Billion by 2031, with a CAGR of 15.29% during the forecast period (2024-2031). The wearable injectors market is witnessing considerable growth owing to the mounting demand for convenient drug delivery techniques, mainly for chronic illnesses like autoimmune diseases and diabetes. These techniques offer advantages, including less need for manual injection, patient compliance, and better comfort. The market is propelled by the rising emphasis on personalized medicine, the growth of biosimilars and biologics, and technological improvements....